Skip to main content
Erschienen in: BMC Medical Imaging 1/2024

Open Access 01.12.2024 | Research

Evaluating the consistency in different methods for measuring left atrium diameters

verfasst von: Jun-Yan Yue, Kai Ji, Hai-Peng Liu, Qing-Wu Wu, Chang-Hua Liang, Jian-Bo Gao

Erschienen in: BMC Medical Imaging | Ausgabe 1/2024

Abstract

Background

The morphological information of the pulmonary vein (PV) and left atrium (LA) is of immense clinical importance for effective atrial fibrillation ablation. The aim of this study is to examine the consistency in different LA diameter measurement techniques.

Methods

Retrospective imaging data from 87 patients diagnosed with PV computed tomography angiography were included. The patients consisted of 50 males and 37 females, with an average age of (60.74 ± 8.70) years. Two physicians independently measured the anteroposterior diameter, long diameter, and transverse diameter of the LA using six different methods. Additionally, we recorded the post-processing time of the images. Physician 1 conducted measurements twice with a one-month interval between the measurements to assess intra-rater reliability. Using the intraclass correlation coefficient (ICC), the consistency of each LA diameter measurement by the two physicians was evaluated. We compared the differences in the LA diameter and the time consumed for measurements using different methods. This was done by employing the rank sum test of a randomized block design (Friedman M test) and the q test for pairwise comparisons among multiple relevant samples.

Results

(1) The consistency of the measured LA diameter by the two physicians was strong or very strong. (2) There were statistical differences in the anteroposterior diameter, long diameter, and transverse diameter of LA assessed using different methods (χ2 = 222.28, 32.74, 293.83, P < 0.001). (3) Different methods for measuring the diameters of LA required different amounts of time (χ2 = 333.10, P < 0.001).

Conclusion

The results of left atrium (LA) diameter measurements conducted by different physicians were found to be reliable. However, the LA diameters obtained through various techniques exhibited variations. It was observed that measuring LA long diameters using only the VR (volume rendering) picture was the most clinically applicable method.
Hinweise
The original version of this article was revised: Figure 6 was mistakenly duplicated to Figure 3 during typesetting. The article has been corrected.
A correction to this article is available online at https://​doi.​org/​10.​1186/​s12880-024-01264-x.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Background

Atrial fibrillation (AF) is a progressive disease with different atrial remodeling symptoms in different stages. In the early stage, it manifests as electrical remodeling, and in the late stage, it manifests as structural remodeling such as atrial fibrosis [1].
Numerous echocardiographic studies have demonstrated the predictive value of atrial diameters in the occurrence, progression or recurrence of AF [27]. Longitudinal remodeling (increase in vertical diameter), transverse diameter, anteroposterior diameter, and volume of left atrium (LA) are associated with the recurrence of AF after radiofrequency ablation or the occurrence of AF [25]. Enlargement of both atriums is an independent predictor of the first ablation following the initial ablation in patients with AF [7]. LA diameters may contribute to identifying patients at high risk for AF [8].
Computed tomography (CT) and magnetic resonance imaging (MRI) are commonly utilized in the advanced stages of cardiac disease. The CT examination is simple and easy, but it is not easy to observe the situation of atrial fibrosis, while MRI Examination takes a longer examination time. [910] Several studies have independently contributed to the understanding of the relationship between LA diameters and AF [1113]. The left interior pulmonary vein (PV) direction and LA diameter, LA anteroposterior diameter enlargement, LA volume index, and mean diameter of PV orifice are all associated with the occurrence and recurrence of AF [1113]. However, it has been observed that the LA volume, LA size, and PV size cannot independently predict the postoperative recurrence of non-paroxysmal AF [14]. According to some studies, there is no morphological or functional sign in heart CT to predict the early recurrence of AF following atrial radiofrequency ablation [15].
In our study, all echocardiographic findings were positive. However, CT and MRI results were somewhat positive and negative, and not all CT results were the same although some were comparable, and different methods were used to measure LA diameter [12, 14]. Only the LA volume, but not their diameters was measured in some studies [13]. However, there are other studies where the LA diameters were measured, but the measurement methods or specific images were not provided [11, 15]. Thus, we hypothesize that the different results are attributable to the respective measuring methods.
Therefore, the purpose of this study is to compare and assess different methods for measuring LA diameters in order to identify clinically applicable methods for measuring LA diameters.

Data and methods

Participants

The Ethics Committee of the First Affiliated Hospital of Xinxiang Medical University approved this study. From January to December 2021, image data from PV computed tomography angiography (CTA) conducted at the First Affiliated Hospital of Xinxiang Medical University were collected and included in the study.

Inclusion and exclusion criteria

Inclusion criteria: (1) all patients with PV CTA; (2) patients with complete and qualified imaging data.
Exclusion criteria: (1) patients with low-quality images who are ineligible for CTA remodeling; (2) patients with non-whole-phase scanning who are ineligible for multiphase remodeling.

CT examination method

The CT machines used were the Canon Aquilion ONE 320 slice CT and GE Revolution 256 slice CT, with the following scanning parameters: 120 kV, auto-milliampere, volume scanning with 1.00 and 1.25 mm slice thickness, and 1.00 and 1.25 mm slice gaps. The required scanning distance was 16 cm, centered on the heart. About 40 ∼ 70 ml of Iopromide Injection 370 (specification: 100 ml: 76.89 g) was administered using a high pressure injector at the rate of 5 ml/s, and the total dose was calculated based on the weight of the patient and drug instructions using the formula: total dose = weight (kg) × (1.0 ∼ 1.5 ml/kg). In general, the CT value of the ascending aorta at the level of the pulmonary artery was monitored 10 s after administration; The CT scanning procedure was initiated when the CT value reached 150 Hounsfield Units (HU), and it could be initiated either automatically or manually. ECG-gating was employed, and the patient was instructed to hold their breath during a normal respiration state prior to the total cardiac cycle scanning. Each patient underwent multi-phase remodeling ranging from 0 to 99% at intervals of 10%, resulting in a total of 10 phases.

Image processing methods

All multiphase images were forwarded to the Canon Vitrea workstation for post-processing. Images of the end-systole (LA diastole) of the left ventricle were chosen.
Volume rendering (VR)① image processing method: VR images of LA were modified independently. The distance from the midpoint of the mitral annulus plane to the dome at the top of LA was measured on a median sagittal plane as the LA long diameter (Fig. 1A); the distance between the anterior and posterior walls of the LA through the midpoint of the long diameter was the LA anteroposterior diameter (Fig. 1A); and the line from the midpoint of the atrial septum to the midpoint of the left lateral wall of LA was measured on a median coronal plane of LA as the LA transverse diameter a (Fig. 1B). The minimum distance of the extension line between the left and right PV orifices was measured on the VR image to represent the transverse diameter (Fig. 1C).
VR② image processing method: In the Cardiac Valves mode pattern, when the VR image shows LAO was displayed at 30° and CRA was displayed at about 60°, selecting the forward-cut mode, the long diameter (Fig. 2A) and transverse diameter of LA were measured at the apical four-chamber plane (Fig. 2B), and when the VR image shows LAO at 145° and CRA at about 0°, selecting the oblique-cut mode, the anteroposterior diameter of LA was measured at the apical two-chamber plane (Fig. 2C).
Multiplanar reformation (MPR)① image processing method: The parasternal left ventricular long axis plane on echocardiography was manually modified to assess the LA anteroposterior diameter (Fig. 3A), the distance from a vertical line taken from the posterior wall of the aorta to the posterior wall of the left atrium was measured (avoiding the enlarged uncoronal sinus wall and pulmonary vein opening); the LA long diameter (the distance from the midpoint of the mitral ring plane to the top of the left atrium) and the transverse diameter (the distance from the midpoint of the atrial septum to the lateral wall of the left atrium) were measured at the apical four-chamber plane based on the Guidelines of Echocardiography Measurement of Chinese Adults (Fig. 3B).
MPR② image processing method: As selected by the system, the LA anteroposterior diameter (the maximum distance between anterior and posterior walls of left atrium) was measured in the apical two-chamber plane (Fig. 4A), while the LA long diameter (the distance from the midpoint of the mitral ring plane to the top of the left atrium)and transverse diameter (the distance from the midpoint of the atrial septum to the lateral wall of the left atrium) were measured at the apical four-chamber plane (Fig. 4B).
MPR③ image processing method: LA diameters were measured on an orthogonal image (Fig. 5) [12]. Measurement of the anteroposterior diameter (represented by MRP③a) and transverse diameter of LA in the maximum axial plane (Fig. 5A), measurement of the LA anteroposterior diameter (represented by MRP③b) at its maximum sagittal plane (Fig. 5B), measurement of the LA long diameter (represented by MRP③a) at the maximum coronal plane (Fig. 5C) and measurement of the LA long diameter (represented by MRP③b) at its maximum sagittal plane (Fig. 5D).
MPR④ image processing method: The transverse diameter and anteroposterior diameter of LA were measured at the midpoint of the transverse diameter at the oblique axis plane, which was the distance between the midpoints of the upper and lower left PV and those of the upper and lower right PV on the oblique axis picture (Fig. 6); the horizontal measurement of the LA long diameter, essentially the distance between the top of LA to the mitral orifice, was the same as the MPR① long diameter measurement, therefore it was not remeasured [14].

Image processing time recording method

The time consumed by each measurement, namely tVR1, tVR2, tMPR1, tMPR2, tMPR3, and tMPR4, was recorded; tVR1 only included the diameter measurement time in the LA VR processing method ①, and did not include the LA remodeling time, as the LA remodeling was routinely conducted in PV CTA post-processing. The LA long diameter processing time for MPR④ processing method was identical to the LA long diameter processing time for MPR① processing method.

Image processing

Image data were measured by two imaging diagnostic physicians who have been working for 15 (physician 1) and 2 (physician 2) years and did not know the purpose of the study; one month later, the image data were measured a second time by physician.

Statistical processing

IBM SPSS Statistics 22.0 (IBM, New York, United States) and Origin2023bSRI software packages were used for statistical analysis of data (OriginLab, Hampton, the US). All measurement data were examined for normal distribution, with those expressing normal distribution represented as mean ± standard deviation, and those non-normally distributed measurement data were expressed as P50 (P25, P75). P < 0.05 indicated statistical differences.
The intraclass correlation coefficient (ICC) is the ratio of individual variance to total variance and is often used to evaluate the consistency of the same quantitative measurement results between different measurement methods or different testers. In this study, we used ICC to evaluate the consistency of a measurement of LA diameter between two physicians, between two measurements by the same physician, and between three measurements by two physicians. ICC < 0.2 indicated poor consistency; 0.2 < ICC < 0.4 indicated common consistency; 0.4 < ICC < 0.6 indicated moderate consistency; 0.6 < ICC < 0.8 indicated strong consistency; 0.8 < ICC < 1.0 indicated very strong consistency.
Initially, the homogeneity of variance (Levene method) was performed on the sample means. In the event of variance heterogeneity, the Friedman test for comparison of multiple correlated samples was conducted to determine if the positions of multiple overall distributions were the same, and the q test for pairwise comparison of multiple correlated samples was conducted if these positions were different. In the Friedman test, P value represented the level of significance difference, where P < 0.05 indicated that there was a significant relationship between the two test results, which meant that the model has a good fitting effect.

Results

Baseline data

The image data of 87 patients were included in the study; All the patients were diagnosed with AF, and included 50 males and 37 females, aged 45 ~ 76 years, with a mean age of (60.74 ± 8.70) years; the LA axis was generally consistent with the left ventricular axis in 46 cases, and was inconsistent in 41 cases; LA was in an erect position or semierect position in 27 cases.

Consistency evaluation of LA diameter measurement by two physicians

The ICC of two measurements of physician 1 (intraclass), the second measurements of physician 1 and physician 2 (interclass), and three measurements of physician 1 and physician 2 were calculated, and the consistency was high or extremely high. Specific results are shown in Table 1.
Table 1
Consistency evaluation of the left atrium (LA) diameters measured by the two physicians (95%CI)
Parameters
Measurement 1 by physician 1
Measurement 2 by physician 1
Measurement by physician 2
Consistency of two measurements by physician 1
physician 1-physician 2 Consistency
Consistency of 3 measurements
 
ICC value
F value
P value
ICC value
F value
P value
ICC value
F value
P value
Anteroposterior diameter
            
VR①
46.34 ± 10.66
45.51 ± 10.17
45.86 ± 10.24
0.94(0.90 ~ 0.96)
29.72
< 0.001
0.95(0.92 ~ 0.97)
38.52
< 0.001
0.95(0.93 ~ 0.97)
59.77
< 0.001
VR②
44.30 ± 8.62
45.03 ± 9.34
44.47 ± 8.32
0.83(0.75 ~ 0.88)
10.57
< 0.001
0.84(0.76 ~ 0.89)
11.32
< 0.001
0.86(0.81 ~ 0.90)
19.33
< 0.001
MPR①
44.39 ± 9.00
43.59 ± 9.21
44.12 ± 8.25
0.90(0.85 ~ 0.94)
19.49
< 0.001
0.90(0.86 ~ 0.94)
19.86
< 0.001
0.92(0.89 ~ 0.94)
35.13
< 0.001
MPR②
53.24 ± 9.26
51.45 ± 9.08
54.19 ± 9.58
0.75(0.64 ~ 0.83)
7.03
< 0.001
0.81(0.72 ~ 0.87)
9.26
< 0.001
0.82(0.76 ~ 0.87)
14.71
< 0.001
MPR③a
44.56 ± 9.20
44.85 ± 9.41
45.00 ± 9.78
0.98(0.96 ~ 0.98)
79.12
< 0.001
0.97(0.96 ~ 0.98)
62.72
< 0.001
0.97(0.96 ~ 0.98)
115.29
< 0.001
MPR③b
44.50 ± 9.26
44.86 ± 9.51
45.00 ± 9.42
0.96(0.94 ~ 0.98)
52.64
< 0.001
0.97(0.95 ~ 0.98)
60.52
< 0.001
0.97(0.96 ~ 0.98)
95.83
< 0.001
MPR④
35.75 ± 7.91
35.88 ± 6.93
35.19 ± 7.08
0.78(0.68 ~ 0.85)
8.06
< 0.001
0.80(0.71 ~ 0.87)
9.08
< 0.001
0.81(0.75 ~ 0.87)
13.98
< 0.001
Long diameter
            
VR①
66.38 ± 7.50
67.89 ± 7.40
66.93 ± 7.48
0.93(0.89 ~ 0.95)
27.04
< 0.001
0.92(0.88 ~ 0.95)
24.50
< 0.001
0.93(0.91 ~ 0.95)
42.91
< 0.001
VR②
62.99 ± 9.56
63.05 ± 8.65
64.09 ± 8.80
0.77(0.66 ~ 0.84)
7.51
< 0.001
0.78(0.68 ~ 0.85)
7.98
< 0.001
0.81(0.74 ~ 0.86)
13.52
< 0.001
MPR①
64.33 ± 10.64
66.09 ± 10.80
64.43 ± 10.45
0.83(0.76 ~ 0.89)
11.01
< 0.001
0.76(0.65 ~ 0.83)
7.17
< 0.001
0.82(0.75 ~ 0.87)
14.28
< 0.001
MPR②
64.78 ± 11.47
64.84 ± 10.49
64.90 ± 11.25
0.91(0.87 ~ 0.94)
21.67
< 0.001
0.92(0.89 ~ 0.95)
25.13
< 0.001
0.93(0.91 ~ 0.95)
43.28
< 0.001
MPR③a
63.30 ± 8.21
64.71 ± 8.03
64.86 ± 7.87
0.87(0.81 ~ 0.91)
14.30
< 0.001
0.88(0.82 ~ 0.92)
15.83
< 0.001
0.94(0.91 ~ 0.96)
47.97
< 0.001
MPR③b
67.77 ± 9.82
66.97 ± 8.99
69.80 ± 9.32
0.89(0.84 ~ 0.93)
17.82
< 0.001
0.87(0.80 ~ 0.91)
13.83
< 0.001
0.89(0.85 ~ 0.93)
26.27
< 0.001
Transverse diameter
            
VR①a
54.70(48.90,58.00)
54.70(50.10,60.00)
54.00(48.70,58.30)
0.93(0.90 ~ 0.96)
28.37
< 0.001
0.94(0.92 ~ 0.96)
34.96
< 0.001
0.94(0.92 ~ 0.96)
49.04
< 0.001
VR①b
57.00(50.50,62.10)
55.50(49.10,62.30)
54.00(48.80,60.00)
0.94(0.92 ~ 0.96)
34.98
< 0.001
0.86(0.79 ~ 0.90)
12.77
< 0.001
0.90(0.86 ~ 0.93)
27.04
< 0.001
VR②
50.20(44.40,56.20)
49.30(45.20,54.50)
50.90(46.60,57.20)
0.84(0.77 ~ 0.90)
11.76
< 0.001
0.82(0.74 ~ 0.88)
9.94
< 0.001
0.86(0.81 ~ 0.90)
19.22
< 0.001
MPR①
52.88 ± 9.34
52.75 ± 8.33
52.52 ± 8.09
0.87(0.81 ~ 0.92)
14.43
< 0.001
0.81(0.72 ~ 0.84)
9.33
< 0.001
0.84(0.78 ~ 0.88)
16.38
< 0.001
MPR②
50.00 ± 9.59
50.50 ± 9.18
50.94 ± 8.82
0.94(0.90 ~ 0.96)
29.93
< 0.001
0.93(0.90 ~ 0.95)
27.663
< 0.001
0.94(0.92 ~ 0.96)
48.77
< 0.001
MPR③
78.00(72.10,83.80)
77.30(70.80,81.90)
79.20(73.70,85.00)
0.92(0.88 ~ 0.95)
24.84
< 0.001
0.94(0.92 ~ 0.96)
34.51
< 0.001
0.94(0.91 ~ 0.96)
45.18
< 0.001
MPR④
57.10(51.70,64.60)
58.50(51.10,64.90)
58.10(52.00,64.80)
0.94(0.91 ~ 0.96)
33.38
< 0.001
0.94(0.91 ~ 0.96)
34.172
< 0.001
0.95(0.93 ~ 0.96)
55.34
< 0.001
(Note VR① refers to the measurement on the VR image of an independent LA remodeling; VR② refers to the measurements on the VR image of the cardiac valves pattern; MPR① refers to the measurement at the ultrasonic plane; MPR② refers to the measurement at the apical two-chamber and four-chamber plane; MPR③ refers to the measurement at the orthogonal plane; MPR④ refers to the measurement at the oblique axis plane; MPR③a of the anteroposterior diameter means measurement at the orthogonal axis plane; MPR③b of the anteroposterior diameter refers to the measurement at the orthogonal sagittal plane; MPR③a of the long diameter refers to the measurement at the coronal plane; MPR③b of the long diameter refers to the measurement at the sagittal plane; VR①a of the transverse diameter refers to the distance between the inner and outer lateral walls of LA; VR①b of the transverse diameter suggests that the minimum distance of the extension line between the left and right PV orifices represents the transverse diameter.)

Homogeneity of variance analysis of LA diameter measurement by different methods

The Levene method was used to analyze the homogeneity of variance for LA diameters measured by different methods. The results indicated that the variance was heterogeneous for the anteroposterior diameter, long diameter, and transverse diameter of LA measured by different methods, with F and P values of the three diameters being 2.16 and 0.045, 3.18 and 0.008, and 2.91 and 0.008, respectively.

Difference in LA diameter measurement by different methods

Based on the Friedman test, there were statistical differences in the anteroposterior diameter, long diameter, and transverse diameter of LA measured by different methods at α = 0.05 (anteroposterior diameter: χ2 = 222.28, P < 0.001, long diameter: χ2 = 32.74, P < 0.001, transverse diameter: χ2 = 293.83, P < 0.001); On the basis of the q test for pairwise comparison of multiple correlated samples (Friedman test) and the Friedman test for multiple gradually decreased correlated samples, there were statistically significant differences between the anteroposterior diameter, long diameter, and transverse diameter of LA measured by various methods (Table 2; Fig. 7).
Table 2
Friedman test results of pairwise comparison of different methods for measuring the left atrium (LA) diameters on the computed tomography (CT) image
Dimension
Measurement methods
Measurement methods
q value
P value
Name
mean ± SD/ P50 (P25, P75)
Name
mean ± SD/ P50 (P25, P75)
Anteroposterior diameter
MPR④
35.88 ± 6.93
MPR①
43.59 ± 9.21
5.95
< 0.001
  
VR②
45.03 ± 9.34
7.53
< 0.001
  
MPR③b
44.86 ± 9.51
7.67
< 0.001
  
MPR③a
44.85 ± 9.41
8.05
< 0.001
  
VR①
45.51 ± 10.17
8.21
< 0.001
  
MPR②
51.45 ± 9.08
14.14
< 0.001
MPR①
43.59 ± 9.21
VR②
45.03 ± 9.34
1.58
1.000
  
MPR③b
44.86 ± 9.51
-1.72
1.000
  
MPR③a
44.85 ± 9.41
-2.11
0.740
  
VR①
45.51 ± 10.17
2.26
0.496
  
MPR②
51.45 ± 9.08
-8.72
< 0.001
VR②
45.03 ± 9.34
MPR③b
44.86 ± 9.51
-0.14
1.000
  
MPR③a
44.85 ± 9.41
-0.53
1.000
  
VR①
45.51 ± 10.17
0.68
1.000
  
MPR②
51.45 ± 9.08
-7.14
< 0.001
MPR③b
44.86 ± 9.51
MPR③a
44.85 ± 9.41
0.39
1.000
  
VR①
45.51 ± 10.17
0.54
1.000
  
MPR②
51.45 ± 9.08
7.00
< 0.001
MPR③a
44.85 ± 9.41
VR①
45.51 ± 10.17
0.16
1.000
  
MPR②
51.45 ± 9.08
6.62
< 0.001
VR①
45.51 ± 10.17
MPR②
51.45 ± 9.08
-6.46
< 0.001
Long diameter
VR②
63.05 ± 8.65
MPR③a
64.71 ± 8.03
-0.041
1.000
  
MPR②
64.84 ± 10.49
-2.48
0.202
  
MPR③b
66.97 ± 8.99
-3.06
0.033
   
MPR①
66.09 ± 10.80
-3.57
0.005
  
VR①
67.89 ± 7.40
4.24
< 0.001
MPR③a
64.71 ± 8.03
MPR②
64.84 ± 10.49
2.43
0.226
  
MPR③b
66.97 ± 8.99
-3.02
0.038
  
MPR①
66.09 ± 10.80
3.53
0.006
  
VR①
67.89 ± 7.40
4.19
< 0.001
MPR②
64.84 ± 10.49
MPR③b
66.97 ± 8.99
-0.59
1.000
  
MPR①
66.09 ± 10.80
1.09
1.000
  
VR①
67.89 ± 7.40
1.76
1.000
MPR③b
66.97 ± 8.99
MPR①
66.09 ± 10.80
0.51
1.000
  
VR①
67.89 ± 7.40
1.12
1.000
MPR①
66.09 ± 10.80
VR①
67.89 ± 7.40
0.67
1.000
Transverse diameter
VR②
49.30 (45.20, 54.50)
MPR②
50.10 (44.10, 56.70)
-1.67
1.000
  
MPR①
49.30 (46.60, 58.50)
-3.90
0.002*
  
VR①b
55.50 (49.10, 62.30)
5.91
< 0.001*
  
VR①a
54.70 (50.10, 60.00)
6.56
< 0.001*
  
MPR④
58.50 (51.10, 64.90)
-8.49
< 0.001*
Transverse diameter
  
MPR③
77.30 (70.80, 81.90)
-14.99
< 0.001*
MPR②
50.10 (44.10, 56.70)
MPR①
49.30 (46.60, 58.50)
0.026
0.543
  
VR①b
55.50 (49.10, 62.30)
4.25
< 0.001*
  
VR①a
54.70 (50.10, 60.00)
4.90
< 0.001*
  
MPR④
58.50 (51.10, 64.90)
-6.83
< 0.001*
  
MPR③
77.30 (70.80, 81.90)
-13.32
< 0.001*
MPR①
49.30 (46.60, 58.50)
VR①b
55.50 (49.10, 62.30)
2.02
0.916
  
VR①a
54.70 (50.10, 60.00)
2.67
0.161
  
MPR④
58.50 (51.10, 64.90)
-4.60
< 0.001*
  
MPR③
77.30 (70.80, 81.90)
-11.09
< 0.001*
VR①b
55.50 (49.10, 62.30)
VR①a
54.70 (50.10, 60.00)
0.65
1.000
  
MPR④
58.50 (51.10, 64.90)
-2.58
0.208
  
MPR③
77.30 (70.80, 81.90)
-9.07
< 0.001*
VR①a
54.70 (50.10, 60.00)
MPR④
58.50 (51.10, 64.90)
-1.93
1.000
  
MPR③
77.30 (70.80, 81.90)
-8.42
< 0.001*
MPR④
58.50 (51.10, 64.90)
MPR③
77.30 (70.80, 81.90)
6.49
< 0.001*
(Note VR① refers to the measurement on the VR image of an independent LA remodeling; VR② refers to the measurements on the VR image of the cardiac valves pattern; MPR① refers to the measurement at the ultrasonic plane; MPR② refers to the measurement at the apical two-chamber and four-chamber plane; MPR③ refers to the measurement at the orthogonal plane; MPR④ refers to the measurement at the oblique axis plane; MPR③a of the anteroposterior diameter means measurement at the orthogonal axis plane; MPR③b of the anteroposterior diameter refers to the measurement at the orthogonal sagittal plane; MPR③a of the long diameter refers to the measurement at the coronal plane; MPR③b of the long diameter refers to the measurement at the sagittal plane; VR①a of the transverse diameter refers to the distance between the inner and outer lateral walls of LA; VR①b of the transverse diameter suggests that the minimum distance of the extension line between the left and right PV orifices represents the transverse diameter.)

Difference in time consumed by different methods for LA diameter measurement

Based on the rank sum test of randomized block design (Friedman test), there were statistical differences in the time required by different LA diameter measurement methods at α = 0.05 (χ2 = 333.10, P < 0.001); based on the Friedman test for multiple gradually decreased correlated samples, there were statistical differences in the time required by different LA diameter measurement methods (Table 3; Fig. 7).
Table 3
Mean rank and homogeneous subset results of Friedman test of different methods for measuring gradually decreased the left atrium (LA) diameters
Anteroposterior diameter
Subsets
Long diameter
Subsets
Transverse diameter
Subsets
1
2
3
1
2
      
MPR④
1.56
   
VR②
2.87
 
VR②
2.06
     
MPR①
 
3.51
  
MPR③a
2.88
 
MPR②
 
2.60
    
VR②
 
4.03
  
MPR②
3.57
3.57
MPR①
  
3.33
   
MPR③a
 
4.07
  
MPR③b
 
3.74
VR①b
   
3.99
  
MPR③b
 
4.20
  
MPR①
 
3.88
VR①a
   
4.21
  
VR①
 
4.25
  
VR①
 
4.07
MPR④
    
4.84
 
MPR②
  
6.37
    
MPR③
     
6.97
q value
 
9.48
  
q value
5.59
2.70
q value
   
0.74
  
P value
 
0.070
  
P value
0.118
0.581
P value
   
0.824
  
(Note VR① refers to the measurement on the VR image of an independent LA remodeling; VR② refers to the measurements on the VR image of the cardiac valves pattern; MPR① refers to the measurement at the ultrasonic plane; MPR② refers to the measurement at the apical two-chamber and four-chamber plane; MPR③ refers to the measurement at the orthogonal plane; MPR④ refers to the measurement at the oblique axis plane; MPR③a of the anteroposterior diameter means measurement at the orthogonal axis plane; MPR③b of the anteroposterior diameter refers to the measurement at the orthogonal sagittal plane; MPR③a of the long diameter refers to the measurement at the coronal plane; MPR③b of the long diameter refers to the measurement at the sagittal plane; VR①a of the transverse diameter refers to the distance between the inner and outer lateral walls of LA; VR①b of the transverse diameter suggests that the minimum distance of the extension line between the left and right PV orifices represents the transverse diameter.)

Discussion

Main discovery of LA diameter measurement

In this study, (1) the consistency of LA diameter measurements between the two physicians was either strong or very strong. (2) The LA diameter estimated using different methods was not identical. (3) LA diameter measurement on VR① and MPR② images required less time compared to LA diameter measurement on other images.
The LA anteroposterior diameter is the maximum vertical diameter of anterior and posterior walls of LA. The LA long diameter is the distance between the midpoint of the mitral annulus plane and the top of LA. The LA transverse diameter is the distance between the midpoint of the atrial septum and the side wall of LA, and it is perpendicular to the long diameter of the LA. Theoretically, all of the diameters measured by VR①, VR②, MPR①, and MPR② methods meet the anatomical definition.

Discussion of measurement methods for LA Anteroposterior diameter

MPR③a and MPR③b were used to measure the maximum distance between the anterior and posterior walls at the maximum axial plane of LA in the orthogonal plane or sagittal plane, and MPR④ were used to measure the distance between the upper left and right PV midpoint and the lower left and right PV midpoint [14]. The LA had an uneven funnel form. Theoretically, the diameter measured by the two methods is not the anatomically localized LA anteroposterior diameter. There were no statistically significant differences in the diameter measured by MPR③ and by VR①, VR②, and MPR①, which only indicated that the measured result was comparable to the actual anteroposterior diameter of the LA. MPR④ yielded the smallest anteroposterior diameter for the LA, indicating that this approach did not accurately assess the anteroposterior diameter.
The LA anteroposterior diameter measured by MPR② was the largest and had the lowest ICC, which may be associated with the inconsistency of LA with the left ventricular axis [16]. In addition, the LA axis was inconsistent with the left ventricular axis in 41 cases (41/87) in this group, whereas the default apical two-chamber plane was the anteroposterior diameter plane of the left ventricle, which may be the oblique anteroposterior diameter plane of LA. Therefore, the LA anteroposterior diameter measured at this plane was larger. Meanwhile, different physicians have different cognitive levels, and some of them may shift the measurement plane to the LA anteroposterior diameter plane depending on their own experience. However, some physicians also measure diameters at the default plane, hence, this measurement method has the lowest ICC in the consistency evaluation of measurement for these physicians and is not suitable for promotion.
VR② for the LA anteroposterior diameter was similar to the MPR② method, in which the LA anteroposterior diameter was assessed on the MPR image. In the VR② method, the anatomical structure was more easily observed, and thus the LA anteroposterior diameter measured by this method was statistically different from those measured by MPR①, MPR③b, MPR③a, and VR① (P > 0.05); the ICC of this method was slightly higher than that of MPR②, but lower than that of other methods. However, this method is time-consuming and therefore not suitable for promotion.
MPR① was compatible with the LA anteroposterior diameter measurement method reported by Stolzmann et al. and Stojanovska et al., that is, the LA anteroposterior diameter was measured at the parasternal left ventricular long axis plane on echocardiography [1719]. The LA anteroposterior diameter determined by this method and by VR②4, MPR③, MPR③a, and VR①4 did not differ statistically (P > 0.05), and the ICC was greater than 0.9. However, this method is more complex and time-consuming than VR①, MPR②, and MPR③, and requires physicians to make adjustments in several aspects (P < 0.001), hence it is not ideal for clinical promotion.
On the VR image of the separate LA remodeling, VR① was used to measure the maximum anteroposterior diameter of LA, which was similar to the LA measurement method provided by Seewöster et al. [20] The difference was that Seewöster et al. measured the diameter based on the MPR image, however our method is more intuitive. In addition, (1) the LA anteroposterior diameter determined by this method is similar to that measured by VR②4, MPR③b, MPR③a, and MPR① (P > 0.05). (2) The ICC of this method is the second highest, behind that of MPR③. (3) This method required the least time, and thus has a high promotion value.

Discussion of measurement methods for LA long diameter

MPR③a and MPR③b were used to measure the maximum coronal plane of LA at the orthogonal plane and the maximum height of LA at the sagittal plane. Theoretically, the diameter measured by this method, is not the anatomically localized LA anteroposterior diameter. In addition, the LA long diameter assessed by MPR③a was smaller than that by MPR① and VR① (P = 0.006, P < 0.0001); however, there were no statistically significant differences between the LA long diameter measured by MPR③b and that measured by MPR①, MPR② and VR①. The reason may be that the top of LA and the mitral annulus are distant from one another in the coronal plane, yet coincide in the sagittal plane. In addition, the ICC of the diameter measured with MPR③a and MPR③b was less than that of the diameter recorded with VR① and MPR②. Therefore, they do not qualify for clinical promotion.
The LA long diameter measured by VR② was the shortest with the least mean rank in this study. It exhibited the lowest ICC, which may have been due to the fact that LA axis and the left ventricular axis were not on the same line [16]. In addition, 27 patients were in an upright position or semierect position, therefore the LA long diameter assessed at the apical four-chamber plane may have been the oblique diameter between the anterior and posterior walls of LA rather than the actual LA long diameter, resulting in the lowest mean rank. At the same time, one of the physicians may have adjusted the plane at which the LA was measured, while the other did not, resulting in a measurement result with the lowest ICC. Therefore, this approach has minimal clinical relevance.
MPR② was comparable to VR② and the method used by Shiro et al. [21], with the exception that MPR2 is based on the MPR image and VR2 is based on the VR image. MPR② has similar deficiencies to VR②, and there are no statistical differences in the LA long diameter measured by the two methods. Therefore, they do not qualify for clinical promotion.
MPR① is essentially the same as in LA long diameter measurement, with the exception that MPR① is based on the manually adjusted plane while MPR② is based on the default plane. The ICC was therefore low. Thus, they do not qualify for promotion.
In the VR① method, the diameter was measured at the separately created sagittal plane or coronal plane of LA, which was determined by the line connecting the peak of LA to the midpoint of mitral annulus. This procedure is similar to the method used by Seewöster et al. [20]. There were no statistically significant differences in the LA long diameter measured by this method and by MPR② and MPR①, indicating the reliability of the results measured by this method; it had the highest ICC, indicating the excellent repeatability of this method, and it required the least time. Therefore, it has high clinical application value.

Discussion of measurement methods for LA transverse diameter

In the MPR③ measurement method, the greatest distance between the inner and outer lateral walls of LA was measured at the maximum axial plane [12]. This method measures the transverse oblique diameter rather than the transverse diameter of LA, which is theoretically bigger than the LA transverse diameter. Moreover, in this study, the LA transverse diameter measured by this method was also the largest. Therefore, this method is not suitable for clinical promotion.
MPR④ and VR①b, two similar measurement methods, were used to measure the distance between two PV midpoints, with the difference being that the former was based on the MPR image and the latter was based on the VR image, which was consistent with the method used by Shimamoto et al. [14] Anatomically, the LA transverse diameter estimated using this method is not accurate. Another four PV lines are varied obviously, which can impact the precision of the measurement data. This method is therefore not suitable for clinical promotion.
Similar to the method used by Shiro et al., MPR①, MPR②, and VR②, are essentially the same measurement methods, that is, the LA transverse diameter is measured at the cardiac chamber plane [21]. The difference is that MPR① and MPR② are derived from the MPR image and VR② is based on the VR image. Anatomically, the LA is irregularly funnel-shaped, and its diameter deviates to varying degrees. In the three methods, the diameter is measured from the center of the atrial septum to the outer lateral wall (left lateral wall) of LA. However, due to the large variance in the outer lateral wall, such as the slope shape of the outer lateral wall when the LA anteroposterior diameter is small, the distance from the atrial septum to the posterior wall of LA is often measured as the transverse diameter and the result is short. In this study, when comparing the LA transverse diameter determined by the three methods using the Friedman test for samples that consistently decreased in size, it was found to be smaller than the measurement taken from the VR image. The three methods also had a strong ICC (ICC > 0.8), which indirectly reflected the differences in the mean rank of the LA transverse diameter measured by the three methods. Therefore, it is difficult to clinically use the three methods to assess the LA transverse diameter.
The VR①a measurement method, in which the LA transverse diameter is assessed on the separate VR image of LA, is similar to the method proposed by Seewöster et al. [20]. The results of this study revealed that there were no statistically significant differences in the LA transverse diameter measured by VR①a and by MPR①, but the mean rank of the former was larger than that of the latter in the Friedman test for gradually decreasing samples. This measurement used clear anatomical landmarks, and the measured LA transverse diameter was slightly larger, indicating that the result measured by this method should be closer to the actual LA transverse diameter. In addition, the ICC of this method was similar to that of MPR②, but greater than those of VR② and MPR①, indicating that this method is repeatable. This method also required the least time. Therefore, it has a higher clinical promotion value.
There are some limitations in this study. ① The results were not compared with echocardiographic data, as only one anteroposterior diameter was measured on echocardiography in the collected cases, which was of little significance to compare; individual data were also used for ultrasonic LA three-dimensional reconstruction, but the data measured by small-sample three-dimensional cardiac ultrasound were not compared with those by CT due to the ineffectiveness of the reconstruction. ② Artificial intelligence is being employed for multivessel measurement and prediction of disease [22], which may be the direction of our future development and efforts while we adopt measurements.

Conclusion

The LA diameter measured by different methods is different. Analysis of data in this study revealed that the LA diameter data measured on the directly reconstructed VR image of the LA could be immediately located and measured according to the anatomical landmark, hence, the results were closer to the actual anatomical results. Based on the comprehensive evaluation from four factors, namely conformity with the anatomical measurement, accuracy of measurement, consistency evaluation of measurers, and measurement time, the VR① method, in which the LA diameter is measured separately on the VR image, is the most appropriate for clinical application.

Acknowledgements

We would like to acknowledge the hard and dedicated work of all the staff that implemented the intervention and evaluation components of the study.

Declarations

This study followed the Declaration of Helsinki and was approved by the Ethics Committee of the First Affiliated Hospital of Xinxiang Medical University. Written informed consent was obtained from all participants.
Not applicable.

Competing interests

The authors declare that they have no competing interests.
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://​creativecommons.​org/​licenses/​by/​4.​0/​. The Creative Commons Public Domain Dedication waiver (http://​creativecommons.​org/​publicdomain/​zero/​1.​0/​) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Literatur
1.
Zurück zum Zitat Chinese Society of Pacing and Electrophyxsiology. Chinese Society of Arrhythmias, Atrial Fiborillatiom Center Union of China. Current knowledge and managemcnt of atrial fibrillation; consensus of Chinese experts 2021. Chin J Cardiac Arrhyth. 2022;26(01):15–88. Chinese Society of Pacing and Electrophyxsiology. Chinese Society of Arrhythmias, Atrial Fiborillatiom Center Union of China. Current knowledge and managemcnt of atrial fibrillation; consensus of Chinese experts 2021. Chin J Cardiac Arrhyth. 2022;26(01):15–88.
2.
Zurück zum Zitat Motoc A, Abugattas JP, Roosens B, et al. Left atrium remodeling predicts late recurrence of paroxysmal atrial fibrillation after second generation cryoballoon ablation. Cardiovasc Ultrasound. 2018;16(1):19.CrossRefPubMedPubMedCentral Motoc A, Abugattas JP, Roosens B, et al. Left atrium remodeling predicts late recurrence of paroxysmal atrial fibrillation after second generation cryoballoon ablation. Cardiovasc Ultrasound. 2018;16(1):19.CrossRefPubMedPubMedCentral
3.
Zurück zum Zitat Klopotowski M, Kwapiszewska A, Kukula K, et al. Clinical and echocardiographic parameters as risk factors for atrial fibrillation in patients with hypertrophic cardiomyopathy. Clin Cardiol. 2018;41(10):1336–40.CrossRefPubMedPubMedCentral Klopotowski M, Kwapiszewska A, Kukula K, et al. Clinical and echocardiographic parameters as risk factors for atrial fibrillation in patients with hypertrophic cardiomyopathy. Clin Cardiol. 2018;41(10):1336–40.CrossRefPubMedPubMedCentral
4.
Zurück zum Zitat Kim YG, Choi JI, Kim MN, et al. Non-vitamin K antagonist oral anticoagulants versus warfarin for the prevention of spontaneous echo-contrast and thrombus in patients with atrial fibrillation or flutter undergoing cardioversion: a trans-esophageal echocardiography study. PLoS ONE. 2018;13(1):e0191648.CrossRefPubMedPubMedCentral Kim YG, Choi JI, Kim MN, et al. Non-vitamin K antagonist oral anticoagulants versus warfarin for the prevention of spontaneous echo-contrast and thrombus in patients with atrial fibrillation or flutter undergoing cardioversion: a trans-esophageal echocardiography study. PLoS ONE. 2018;13(1):e0191648.CrossRefPubMedPubMedCentral
5.
Zurück zum Zitat Wang Q, Zhuo C, Shang Y, et al. U-Shaped relationship between Left Atrium size on Echocardiography and 1-Year recurrence of Atrial Fibrillation after Radiofrequency catheter ablation - prognostic value study. Circ J. 2019;83(7):1463–71.CrossRefPubMed Wang Q, Zhuo C, Shang Y, et al. U-Shaped relationship between Left Atrium size on Echocardiography and 1-Year recurrence of Atrial Fibrillation after Radiofrequency catheter ablation - prognostic value study. Circ J. 2019;83(7):1463–71.CrossRefPubMed
6.
Zurück zum Zitat Magne J, Salerno B, Mohty D, et al. Echocardiography is useful to predict postoperative atrial fibrillation in patients undergoing isolated coronary bypass surgery: a prospective study. Eur Heart J Acute Cardiovasc Care. 2019;8(2):104–13.CrossRefPubMed Magne J, Salerno B, Mohty D, et al. Echocardiography is useful to predict postoperative atrial fibrillation in patients undergoing isolated coronary bypass surgery: a prospective study. Eur Heart J Acute Cardiovasc Care. 2019;8(2):104–13.CrossRefPubMed
7.
8.
Zurück zum Zitat Higashiyama A, Kokubo Y, Watanabe M, et al. Echocardiographic parameters and the risk of Incident Atrial Fibrillation: the Suita Study. J Epidemiol. 2020;30(4):183–7.CrossRefPubMedPubMedCentral Higashiyama A, Kokubo Y, Watanabe M, et al. Echocardiographic parameters and the risk of Incident Atrial Fibrillation: the Suita Study. J Epidemiol. 2020;30(4):183–7.CrossRefPubMedPubMedCentral
9.
Zurück zum Zitat Hosseinzadeh M, Gorji A, Fathi Jouzdani A, Rezaeijo SM, Rahmim A, Salmanpour MR. Prediction of Cognitive decline in Parkinson’s Disease using clinical and DAT SPECT Imaging features, and Hybrid Machine Learning systems. Diagnostics (Basel). 2023;13(10):1691.CrossRefPubMed Hosseinzadeh M, Gorji A, Fathi Jouzdani A, Rezaeijo SM, Rahmim A, Salmanpour MR. Prediction of Cognitive decline in Parkinson’s Disease using clinical and DAT SPECT Imaging features, and Hybrid Machine Learning systems. Diagnostics (Basel). 2023;13(10):1691.CrossRefPubMed
10.
Zurück zum Zitat Heydarheydari S, Birgani MJT, Rezaeijo SM. Auto-segmentation of head and neck tumors in positron emission tomography images using non-local means and morphological frameworks. Pol J Radiol. 2023;88:e365–70.CrossRefPubMedPubMedCentral Heydarheydari S, Birgani MJT, Rezaeijo SM. Auto-segmentation of head and neck tumors in positron emission tomography images using non-local means and morphological frameworks. Pol J Radiol. 2023;88:e365–70.CrossRefPubMedPubMedCentral
11.
Zurück zum Zitat Kocyigit D, Yalcin MU, Gurses KM, et al. Pulmonary vein orientation is independently associated with outcomes following cryoballoon-based atrial fibrillation ablation. J Cardiovasc Comput Tomogr. 2018;12(4):281–5.CrossRefPubMed Kocyigit D, Yalcin MU, Gurses KM, et al. Pulmonary vein orientation is independently associated with outcomes following cryoballoon-based atrial fibrillation ablation. J Cardiovasc Comput Tomogr. 2018;12(4):281–5.CrossRefPubMed
12.
Zurück zum Zitat van den Berg NWE, Chan Pin Yin D, Berger WR, et al. Comparison of non-triggered magnetic resonance imaging and echocardiography for the assessment of left atrial volume and morphology. Cardiovasc Ultrasound. 2018;16(1):17.CrossRefPubMedPubMedCentral van den Berg NWE, Chan Pin Yin D, Berger WR, et al. Comparison of non-triggered magnetic resonance imaging and echocardiography for the assessment of left atrial volume and morphology. Cardiovasc Ultrasound. 2018;16(1):17.CrossRefPubMedPubMedCentral
13.
Zurück zum Zitat Rettmann ME, Holmes DR 3rd, Monahan KH, et al. Treatment-related changes in Left Atrial structure in Atrial Fibrillation: findings from the CABANA Imaging Substudy. Circ Arrhythm Electrophysiol. 2021;14(5):e008540.CrossRefPubMedPubMedCentral Rettmann ME, Holmes DR 3rd, Monahan KH, et al. Treatment-related changes in Left Atrial structure in Atrial Fibrillation: findings from the CABANA Imaging Substudy. Circ Arrhythm Electrophysiol. 2021;14(5):e008540.CrossRefPubMedPubMedCentral
14.
Zurück zum Zitat Shimamoto K, Miura F, Shimatani Y, Nishioka K, Inoue I. Pulmonary vein volume predicts the outcome of radiofrequency catheter ablation of paroxysmal atrial fibrillation. PLoS ONE. 2018;13(7):e0201199.CrossRefPubMedPubMedCentral Shimamoto K, Miura F, Shimatani Y, Nishioka K, Inoue I. Pulmonary vein volume predicts the outcome of radiofrequency catheter ablation of paroxysmal atrial fibrillation. PLoS ONE. 2018;13(7):e0201199.CrossRefPubMedPubMedCentral
15.
Zurück zum Zitat Ebersberger U, Bernard ML, Schoepf UJ, et al. Cardiac Computed Tomography for Atrial Fibrillation patients undergoing ablation: implications for the prediction of early recurrence. J Thorac Imaging. 2020;35(3):186–92.CrossRefPubMed Ebersberger U, Bernard ML, Schoepf UJ, et al. Cardiac Computed Tomography for Atrial Fibrillation patients undergoing ablation: implications for the prediction of early recurrence. J Thorac Imaging. 2020;35(3):186–92.CrossRefPubMed
16.
Zurück zum Zitat Al-Mohaissen MA, Kazmi MH, Chan KL, Chow BJ. Validation of two-dimensional methods for left atrial volume measurement: a comparison of echocardiography with cardiac computed tomography. Echocardiography. 2013;30(10):1135–42.CrossRefPubMed Al-Mohaissen MA, Kazmi MH, Chan KL, Chow BJ. Validation of two-dimensional methods for left atrial volume measurement: a comparison of echocardiography with cardiac computed tomography. Echocardiography. 2013;30(10):1135–42.CrossRefPubMed
17.
Zurück zum Zitat Stolzmann P, Scheffel H, Leschka S, et al. Reference values for quantitative left ventricular and left atrial measurements in cardiac computed tomography. Eur Radiol. 2008;18(8):1625–34.CrossRefPubMed Stolzmann P, Scheffel H, Leschka S, et al. Reference values for quantitative left ventricular and left atrial measurements in cardiac computed tomography. Eur Radiol. 2008;18(8):1625–34.CrossRefPubMed
18.
Zurück zum Zitat Stojanovska J, Cronin P, Patel S, Gross BH, Oral H, Chughtai K, Kazerooni EA. Reference normal absolute and indexed values from ECG-gated MDCT: left atrial volume, function, and diameter. AJR Am J Roentgenol. 2011;197(3):631-7. https://doi.org/10.2214/AJR.10.5955. PMID: 21862805. Stojanovska J, Cronin P, Patel S, Gross BH, Oral H, Chughtai K, Kazerooni EA. Reference normal absolute and indexed values from ECG-gated MDCT: left atrial volume, function, and diameter. AJR Am J Roentgenol. 2011;197(3):631-7. https://​doi.​org/​10.​2214/​AJR.​10.​5955. PMID: 21862805.
19.
Zurück zum Zitat Echocardiography Group, Chinese Society of Ultrasound Medicine. Guidelines for measurement of echocardiography in Chinese adults. Chin J Ultrasonogr. 2016;25(8):645–66. Echocardiography Group, Chinese Society of Ultrasound Medicine. Guidelines for measurement of echocardiography in Chinese adults. Chin J Ultrasonogr. 2016;25(8):645–66.
20.
Zurück zum Zitat Seewöster T, Büttner P, Nedios S, et al. Association between Cardiovascular Magnetic Resonance-Derived Left Atrial Dimensions, Electroanatomical substrate and NT-proANP levels in Atrial Fibrillation. J Am Heart Assoc. 2018;7(19):e009427.CrossRefPubMedPubMedCentral Seewöster T, Büttner P, Nedios S, et al. Association between Cardiovascular Magnetic Resonance-Derived Left Atrial Dimensions, Electroanatomical substrate and NT-proANP levels in Atrial Fibrillation. J Am Heart Assoc. 2018;7(19):e009427.CrossRefPubMedPubMedCentral
21.
Zurück zum Zitat Nakamori S, Ngo LH, Tugal D, Manning WJ, Nezafat R. Incremental value of Left Atrial Geometric Remodeling in Predicting Late Atrial Fibrillation recurrence after pulmonary vein isolation: a Cardiovascular magnetic resonance study. J Am Heart Assoc. 2018;7(19):e009793.CrossRefPubMedPubMedCentral Nakamori S, Ngo LH, Tugal D, Manning WJ, Nezafat R. Incremental value of Left Atrial Geometric Remodeling in Predicting Late Atrial Fibrillation recurrence after pulmonary vein isolation: a Cardiovascular magnetic resonance study. J Am Heart Assoc. 2018;7(19):e009793.CrossRefPubMedPubMedCentral
22.
Zurück zum Zitat Khanfari H, Mehranfar S, Cheki M, Mohammadi Sadr M, Moniri S, Heydarheydari S, Rezaeijo SM. Exploring the efficacy of multi-flavored feature extraction with radiomics and deep features for prostate cancer grading on mpMRI. BMC Med Imaging. 2023;23(1):195.CrossRefPubMedPubMedCentral Khanfari H, Mehranfar S, Cheki M, Mohammadi Sadr M, Moniri S, Heydarheydari S, Rezaeijo SM. Exploring the efficacy of multi-flavored feature extraction with radiomics and deep features for prostate cancer grading on mpMRI. BMC Med Imaging. 2023;23(1):195.CrossRefPubMedPubMedCentral
Metadaten
Titel
Evaluating the consistency in different methods for measuring left atrium diameters
verfasst von
Jun-Yan Yue
Kai Ji
Hai-Peng Liu
Qing-Wu Wu
Chang-Hua Liang
Jian-Bo Gao
Publikationsdatum
01.12.2024
Verlag
BioMed Central
Erschienen in
BMC Medical Imaging / Ausgabe 1/2024
Elektronische ISSN: 1471-2342
DOI
https://doi.org/10.1186/s12880-024-01231-6

Weitere Artikel der Ausgabe 1/2024

BMC Medical Imaging 1/2024 Zur Ausgabe

Mammakarzinom: Brustdichte beeinflusst rezidivfreies Überleben

26.05.2024 Mammakarzinom Nachrichten

Frauen, die zum Zeitpunkt der Brustkrebsdiagnose eine hohe mammografische Brustdichte aufweisen, haben ein erhöhtes Risiko für ein baldiges Rezidiv, legen neue Daten nahe.

„Übersichtlicher Wegweiser“: Lauterbachs umstrittener Klinik-Atlas ist online

17.05.2024 Klinik aktuell Nachrichten

Sie sei „ethisch geboten“, meint Gesundheitsminister Karl Lauterbach: mehr Transparenz über die Qualität von Klinikbehandlungen. Um sie abzubilden, lässt er gegen den Widerstand vieler Länder einen virtuellen Klinik-Atlas freischalten.

Klinikreform soll zehntausende Menschenleben retten

15.05.2024 Klinik aktuell Nachrichten

Gesundheitsminister Lauterbach hat die vom Bundeskabinett beschlossene Klinikreform verteidigt. Kritik an den Plänen kommt vom Marburger Bund. Und in den Ländern wird über den Gang zum Vermittlungsausschuss spekuliert.

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.